-
1
-
-
84857913363
-
Latest advances and current challenges in the treatment of multiple myeloma
-
Mahindra A, Laubach J, Raje N, Munshi N, Richardson PG, Anderson K. Latest advances and current challenges in the treatment of multiple myeloma. Nat Rev Clin Oncol. 2012;9(3):135-143.
-
(2012)
Nat Rev Clin Oncol
, vol.9
, Issue.3
, pp. 135-143
-
-
Mahindra, A.1
Laubach, J.2
Raje, N.3
Munshi, N.4
Richardson, P.G.5
Anderson, K.6
-
2
-
-
85027950818
-
Update on risk stratification and treatment of newly diagnosed multiple myeloma
-
Kapoor P, Rajkumar SV. Update on risk stratification and treatment of newly diagnosed multiple myeloma. Int J Hematol. 2011;94(4):310-320.
-
(2011)
Int J Hematol
, vol.94
, Issue.4
, pp. 310-320
-
-
Kapoor, P.1
Rajkumar, S.V.2
-
3
-
-
79952781038
-
Medical Progress Multiple Myeloma
-
Palumbo A, Anderson K. Medical Progress Multiple Myeloma. New Engl J Med. 2011;364(11):1046-1060.
-
(2011)
New Engl J Med
, vol.364
, Issue.11
, pp. 1046-1060
-
-
Palumbo, A.1
Anderson, K.2
-
5
-
-
74049162897
-
International Myeloma Working Group molecular classification of multiple myeloma: Spotlight review
-
Fonseca R, et al. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia. 2009;23(12):2210-2221.
-
(2009)
Leukemia
, vol.23
, Issue.12
, pp. 2210-2221
-
-
Fonseca, R.1
-
6
-
-
84867158927
-
Molecular pathogenesis of multiple myeloma and its premalignant precursor
-
Kuehl WM, Bergsagel PL. Molecular pathogenesis of multiple myeloma and its premalignant precursor. J Clin Invest. 2012;122(10):3456-3463.
-
(2012)
J Clin Invest
, vol.122
, Issue.10
, pp. 3456-3463
-
-
Kuehl, W.M.1
Bergsagel, P.L.2
-
7
-
-
84905705842
-
Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma
-
Affer M, et al. Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma. Leukemia. 2014;28(8):1725-1735.
-
(2014)
Leukemia
, vol.28
, Issue.8
, pp. 1725-1735
-
-
Affer, M.1
-
8
-
-
0028946686
-
Signaling mechanisms through cytokine receptors that share signal transducing receptor components
-
Taga T, Kishimoto T. Signaling mechanisms through cytokine receptors that share signal transducing receptor components. Curr Opin Immunol. 1995;7(1):17-23.
-
(1995)
Curr Opin Immunol
, vol.7
, Issue.1
, pp. 17-23
-
-
Taga, T.1
Kishimoto, T.2
-
9
-
-
0029080019
-
Membrane-bound and soluble interleukin-6 receptor: Studies on structure, regulation of expression, and signal transduction
-
Heinrich PC, et al. Membrane-bound and soluble interleukin-6 receptor: studies on structure, regulation of expression, and signal transduction. Ann N Y Acad Sci. 1995;762:222-236.
-
(1995)
Ann N Y Acad Sci
, vol.762
, pp. 222-236
-
-
Heinrich, P.C.1
-
10
-
-
0034023759
-
The Jak-STAT pathway
-
Imada K, Leonard WJ. The Jak-STAT pathway. Mol Immunol. 2000;37(1-2):1-11.
-
(2000)
Mol Immunol
, vol.37
, Issue.1-2
, pp. 1-11
-
-
Imada, K.1
Leonard, W.J.2
-
11
-
-
34547106018
-
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
-
Hideshima T, Mitsiades C, Tonon G, Richardson PG, Anderson KC. Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer. 2007;7(8):585-598.
-
(2007)
Nat Rev Cancer
, vol.7
, Issue.8
, pp. 585-598
-
-
Hideshima, T.1
Mitsiades, C.2
Tonon, G.3
Richardson, P.G.4
Anderson, K.C.5
-
12
-
-
79952452004
-
The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival
-
Scuto A, et al. The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival. Leukemia. 2011;25(3):538-550.
-
(2011)
Leukemia
, vol.25
, Issue.3
, pp. 538-550
-
-
Scuto, A.1
-
13
-
-
83555174315
-
The novel JAK inhibitor CYT387 suppresses multiple signalling pathways, prevents proliferation and induces apoptosis in phenotypically diverse myeloma cells
-
Monaghan KA, Khong T, Burns CJ, Spencer A. The novel JAK inhibitor CYT387 suppresses multiple signalling pathways, prevents proliferation and induces apoptosis in phenotypically diverse myeloma cells. Leukemia. 2011;25(12):1891-1899.
-
(2011)
Leukemia
, vol.25
, Issue.12
, pp. 1891-1899
-
-
Monaghan, K.A.1
Khong, T.2
Burns, C.J.3
Spencer, A.4
-
14
-
-
33644866173
-
Novel therapeutic strategies targeting growth factor signalling cascades in multiple myeloma
-
Yasui H, Hideshima T, Richardson PG, Anderson KC. Novel therapeutic strategies targeting growth factor signalling cascades in multiple myeloma. Br J Haematol. 2006;132(4):385-397.
-
(2006)
Br J Haematol
, vol.132
, Issue.4
, pp. 385-397
-
-
Yasui, H.1
Hideshima, T.2
Richardson, P.G.3
Anderson, K.C.4
-
15
-
-
33750298971
-
Pyridone 6, a pan-Janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells
-
Pedranzini L, et al. Pyridone 6, a pan-Janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells. Cancer Res. 2006;66(19):9714-9721.
-
(2006)
Cancer Res
, vol.66
, Issue.19
, pp. 9714-9721
-
-
Pedranzini, L.1
-
16
-
-
0037022341
-
IL-6 transgenic mouse model for extraosseous plasmacytoma
-
Kovalchuk AL, et al. IL-6 transgenic mouse model for extraosseous plasmacytoma. Proc Natl Acad Sci U S A. 2002;99(3):1509-1514.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, Issue.3
, pp. 1509-1514
-
-
Kovalchuk, A.L.1
-
17
-
-
0022380768
-
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
-
Adams JM, et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature. 1985;318(6046):533-538.
-
(1985)
Nature
, vol.318
, Issue.6046
, pp. 533-538
-
-
Adams, J.M.1
-
18
-
-
34047136169
-
The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis
-
Carrasco DR, et al. The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis. Cancer Cell. 2007;11(4):349-360.
-
(2007)
Cancer Cell
, vol.11
, Issue.4
, pp. 349-360
-
-
Carrasco, D.R.1
-
19
-
-
19444385692
-
Stat3 regulates genes common to both wound healing and cancer
-
Dauer DJ, et al. Stat3 regulates genes common to both wound healing and cancer. Oncogene. 2005;24(21):3397-3408.
-
(2005)
Oncogene
, vol.24
, Issue.21
, pp. 3397-3408
-
-
Dauer, D.J.1
-
20
-
-
79951494668
-
Initial genome sequencing and analysis of multiple myeloma
-
Chapman MA, et al. Initial genome sequencing and analysis of multiple myeloma. Nature. 2011;471(7339):467-472.
-
(2011)
Nature
, vol.471
, Issue.7339
, pp. 467-472
-
-
Chapman, M.A.1
-
21
-
-
33745779502
-
The molecular classification of multiple myeloma
-
Zhan F, et al. The molecular classification of multiple myeloma. Blood. 2006;108(6):2020-2028.
-
(2006)
Blood
, vol.108
, Issue.6
, pp. 2020-2028
-
-
Zhan, F.1
-
22
-
-
0027958212
-
Proliferative responses and binding properties of hematopoietic cells transfected with low-affinity receptors for leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor
-
Gearing DP, et al. Proliferative responses and binding properties of hematopoietic cells transfected with low-affinity receptors for leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor. Proc Natl Acad Sci U S A. 1994;91(3):1119-1123.
-
(1994)
Proc Natl Acad Sci U S A
, vol.91
, Issue.3
, pp. 1119-1123
-
-
Gearing, D.P.1
-
23
-
-
33745598848
-
Forced dimerization of gp130 leads to constitutive STAT3 activation, cytokine-independent growth, and blockade of differentiation of embryonic stem cells
-
Stuhlmann-Laeisz C, et al. Forced dimerization of gp130 leads to constitutive STAT3 activation, cytokine-independent growth, and blockade of differentiation of embryonic stem cells. Mol Biol Cell. 2006;17(7):2986-2995.
-
(2006)
Mol Biol Cell
, vol.17
, Issue.7
, pp. 2986-2995
-
-
Stuhlmann-Laeisz, C.1
-
24
-
-
0043091984
-
The oncogenic fusion protein nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) induces two distinct malignant phenotypes in a murine retroviral transplantation model
-
Miething C, et al. The oncogenic fusion protein nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) induces two distinct malignant phenotypes in a murine retroviral transplantation model. Oncogene. 2003;22(30):4642-4647.
-
(2003)
Oncogene
, vol.22
, Issue.30
, pp. 4642-4647
-
-
Miething, C.1
-
26
-
-
40849151008
-
Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders
-
Rawstron AC, et al. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica. 2008;93(3):431-438.
-
(2008)
Haematologica
, vol.93
, Issue.3
, pp. 431-438
-
-
Rawstron, A.C.1
-
27
-
-
1842555117
-
Heterogeneity in the multiple myeloma tumor clone
-
Guikema JEJ, Hovenga S, Vellenga E, Bos NA. Heterogeneity in the multiple myeloma tumor clone. Leuk Lymphoma. 2004;45(5):857-871.
-
(2004)
Leuk Lymphoma
, vol.45
, Issue.5
, pp. 857-871
-
-
Guikema, J.E.J.1
Hovenga, S.2
Vellenga, E.3
Bos, N.A.4
-
28
-
-
73949153879
-
INCB16562, a JAK1/2 selective inhibitor, is efficacious against multiple myeloma cells and reverses the protective effects of cytokine and stromal cell support
-
Li J, et al. INCB16562, a JAK1/2 selective inhibitor, is efficacious against multiple myeloma cells and reverses the protective effects of cytokine and stromal cell support. Neoplasia. 2010;12(1):28-38.
-
(2010)
Neoplasia
, vol.12
, Issue.1
, pp. 28-38
-
-
Li, J.1
-
29
-
-
0037082497
-
Stromal cell lines from mouse aorta-gonads-mesonephros subregions are potent supporters of hematopoietic stem cell activity
-
Oostendorp RA, et al. Stromal cell lines from mouse aorta-gonads-mesonephros subregions are potent supporters of hematopoietic stem cell activity. Blood. 2002;99(4):1183-1189.
-
(2002)
Blood
, vol.99
, Issue.4
, pp. 1183-1189
-
-
Oostendorp, R.A.1
-
30
-
-
1342288971
-
Opinion - Comparative biology of mouse versus human cells: Modelling human cancer in mice
-
Rangarajan A, Weinberg RA. Opinion - Comparative biology of mouse versus human cells: modelling human cancer in mice. Nat Rev Cancer. 2003;3(12):952-959.
-
(2003)
Nat Rev Cancer
, vol.3
, Issue.12
, pp. 952-959
-
-
Rangarajan, A.1
Weinberg, R.A.2
-
31
-
-
77954058175
-
Myc suppression of Nfkb2 accelerates lymphomagenesis
-
Keller U, et al. Myc suppression of Nfkb2 accelerates lymphomagenesis. BMC Cancer. 2010;10:348.
-
(2010)
BMC Cancer
, vol.10
, pp. 348
-
-
Keller, U.1
-
32
-
-
77949681500
-
Skp2 directs Myc-mediated suppression of p27Kip1 yet has modest effects on Myc-driven lymphomagenesis
-
Old JB, et al. Skp2 directs Myc-mediated suppression of p27Kip1 yet has modest effects on Myc-driven lymphomagenesis. Mol Cancer Res. 2010;8(3):353-362.
-
(2010)
Mol Cancer Res
, vol.8
, Issue.3
, pp. 353-362
-
-
Old, J.B.1
-
33
-
-
77956588949
-
Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state
-
den Hollander J, et al. Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state. Blood. 2010;116(9):1498-1505.
-
(2010)
Blood
, vol.116
, Issue.9
, pp. 1498-1505
-
-
Den Hollander, J.1
-
34
-
-
35948946514
-
FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf
-
Bouchard C, Lee S, Paulus-Hock V, Loddenkemper C, Eilers M, Schmitt CA. FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf. Genes Dev. 2007;21(21):2775-2787.
-
(2007)
Genes Dev
, vol.21
, Issue.21
, pp. 2775-2787
-
-
Bouchard, C.1
Lee, S.2
Paulus-Hock, V.3
Loddenkemper, C.4
Eilers, M.5
Schmitt, C.A.6
-
35
-
-
0030041147
-
Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-κB
-
Chauhan D, et al. Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-κB. Blood. 1996;87(3):1104-1112.
-
(1996)
Blood
, vol.87
, Issue.3
, pp. 1104-1112
-
-
Chauhan, D.1
-
36
-
-
0023849455
-
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
-
Kawano M, et al. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature. 1988;332(6159):83-85.
-
(1988)
Nature
, vol.332
, Issue.6159
, pp. 83-85
-
-
Kawano, M.1
-
37
-
-
0030057701
-
Soluble interleukin-6 receptor as a prognostic factor in multiple myeloma
-
Finnish Leukaemia Group
-
Pulkki K, Pelliniemi TT, Rajamaki A, Tienhaara A, Laakso M, Lahtinen R. Soluble interleukin-6 receptor as a prognostic factor in multiple myeloma. Finnish Leukaemia Group. Br J Haematol. 1996;92(2):370-374.
-
(1996)
Br J Haematol
, vol.92
, Issue.2
, pp. 370-374
-
-
Pulkki, K.1
Pelliniemi, T.T.2
Rajamaki, A.3
Tienhaara, A.4
Laakso, M.5
Lahtinen, R.6
-
38
-
-
0024832002
-
Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias
-
Bataille R, Jourdan M, Zhang XG, Klein B. Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. J Clin Invest. 1989;84(6):2008-2011.
-
(1989)
J Clin Invest
, vol.84
, Issue.6
, pp. 2008-2011
-
-
Bataille, R.1
Jourdan, M.2
Zhang, X.G.3
Klein, B.4
-
39
-
-
9344259121
-
Human interleukin-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells
-
Sporeno E, et al. Human interleukin-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells. Blood. 1996;87(11):4510-4519.
-
(1996)
Blood
, vol.87
, Issue.11
, pp. 4510-4519
-
-
Sporeno, E.1
-
40
-
-
0032984589
-
Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
-
Catlett-Falcone R, et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity. 1999;10(1):105-115.
-
(1999)
Immunity
, vol.10
, Issue.1
, pp. 105-115
-
-
Catlett-Falcone, R.1
-
41
-
-
9444273447
-
Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells
-
Chatterjee M, Stuhmer T, Herrmann P, Bommert K, Dorken B, Bargou RC. Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells. Blood. 2004;104(12):3712-3721.
-
(2004)
Blood
, vol.104
, Issue.12
, pp. 3712-3721
-
-
Chatterjee, M.1
Stuhmer, T.2
Herrmann, P.3
Bommert, K.4
Dorken, B.5
Bargou, R.C.6
-
42
-
-
0036839144
-
In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway
-
Chatterjee M, et al. In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway. Blood. 2002;100(9):3311-3318.
-
(2002)
Blood
, vol.100
, Issue.9
, pp. 3311-3318
-
-
Chatterjee, M.1
-
43
-
-
9144231336
-
Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation
-
Brocke-Heidrich K, et al. Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation. Blood. 2004;103(1):242-251.
-
(2004)
Blood
, vol.103
, Issue.1
, pp. 242-251
-
-
Brocke-Heidrich, K.1
-
44
-
-
0037408535
-
Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events
-
Quintanilla-Martinez L, et al. Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events. Am J Pathol. 2003;162(5):1449-1461.
-
(2003)
Am J Pathol
, vol.162
, Issue.5
, pp. 1449-1461
-
-
Quintanilla-Martinez, L.1
-
45
-
-
70350500225
-
STATs in cancer inflammation and immunity: A leading role for STAT3
-
Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009;9(11):798-809.
-
(2009)
Nat Rev Cancer
, vol.9
, Issue.11
, pp. 798-809
-
-
Yu, H.1
Pardoll, D.2
Jove, R.3
-
46
-
-
0141864362
-
c-Myc augments gamma irradiation-induced apoptosis by suppressing Bcl-XL
-
Maclean KH, Keller UB, Rodriguez-Galindo C, Nilsson JA, Cleveland JL. c-Myc augments gamma irradiation-induced apoptosis by suppressing Bcl-XL. Mol Cell Biol. 2003;23(20):7256-7270.
-
(2003)
Mol Cell Biol
, vol.23
, Issue.20
, pp. 7256-7270
-
-
Maclean, K.H.1
Keller, U.B.2
Rodriguez-Galindo, C.3
Nilsson, J.A.4
Cleveland, J.L.5
-
47
-
-
3042806890
-
Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice
-
Cheung WC, et al. Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice. J Clin Invest. 2004;113(12):1763-1773.
-
(2004)
J Clin Invest
, vol.113
, Issue.12
, pp. 1763-1773
-
-
Cheung, W.C.1
-
48
-
-
85014285855
-
Distinct IL-6 signal transduction leads to growth arrest and death in B cells or growth promotion and cell survival in myeloma cells
-
Cheung WC, Van Ness B. Distinct IL-6 signal transduction leads to growth arrest and death in B cells or growth promotion and cell survival in myeloma cells. Leukemia. 2002;16(6):1182-1188.
-
(2002)
Leukemia
, vol.16
, Issue.6
, pp. 1182-1188
-
-
Cheung, W.C.1
Van Ness, B.2
-
49
-
-
8844264524
-
The SCID-rab model: A novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells
-
Yata K, Yaccoby S. The SCID-rab model: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells. Leukemia. 2004;18(11):1891-1897.
-
(2004)
Leukemia
, vol.18
, Issue.11
, pp. 1891-1897
-
-
Yata, K.1
Yaccoby, S.2
-
50
-
-
38549131395
-
AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies
-
Chesi M, et al. AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies. Cancer Cell. 2008;13(2):167-180.
-
(2008)
Cancer Cell
, vol.13
, Issue.2
, pp. 167-180
-
-
Chesi, M.1
-
51
-
-
34249097128
-
Myc targets Cks1 to provoke the suppression of p27Kip1, proliferation and lymphomagenesis
-
Keller UB, et al. Myc targets Cks1 to provoke the suppression of p27Kip1, proliferation and lymphomagenesis. EMBO J. 2007;26(10):2562-2574.
-
(2007)
EMBO J
, vol.26
, Issue.10
, pp. 2562-2574
-
-
Keller, U.B.1
-
52
-
-
33646487924
-
The Bcr-Abl mutations T315I and Y253H do not confer a growth advantage in the absence of imatinib
-
Miething C, et al. The Bcr-Abl mutations T315I and Y253H do not confer a growth advantage in the absence of imatinib. Leukemia. 2006;20(4):650-657.
-
(2006)
Leukemia
, vol.20
, Issue.4
, pp. 650-657
-
-
Miething, C.1
-
53
-
-
84862070506
-
Cks1 is required for tumor cell proliferation but not sufficient to induce hematopoietic malignancies
-
Kratzat S, et al. Cks1 is required for tumor cell proliferation but not sufficient to induce hematopoietic malignancies. PLoS One. 2012;7(5):e37433.
-
(2012)
PLoS One
, vol.7
, Issue.5
, pp. e37433
-
-
Kratzat, S.1
-
54
-
-
80755140040
-
Deregulated apoptosis signaling in core-binding factor leukemia differentiates clinically relevant, molecular marker-independent subgroups
-
Luck SC, et al. Deregulated apoptosis signaling in core-binding factor leukemia differentiates clinically relevant, molecular marker-independent subgroups. Leukemia. 2011;25(11):1728-1738.
-
(2011)
Leukemia
, vol.25
, Issue.11
, pp. 1728-1738
-
-
Luck, S.C.1
-
55
-
-
27344435774
-
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
-
Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545-15550.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, Issue.43
, pp. 15545-15550
-
-
Subramanian, A.1
-
56
-
-
0033925065
-
Simplified labeling approach for synthesizing 3-deoxy-3-[18F] fluorothymidine ([18F] FLT)
-
Machulla HJ, Blocher A, Kuntzsch M, Piert M, Wei R, Grierson J. Simplified labeling approach for synthesizing 3-deoxy-3-[18F] fluorothymidine ([18F] FLT). J Radioanal Nucl Chem. 2000;243(3):843-846.
-
(2000)
J Radioanal Nucl Chem
, vol.243
, Issue.3
, pp. 843-846
-
-
Machulla, H.J.1
Blocher, A.2
Kuntzsch, M.3
Piert, M.4
Wei, R.5
Grierson, J.6
|